These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 15337540)

  • 61. Low-dose radiotherapy for Stage I seminoma--long-term results.
    Niewald M; Freyd J; Fleckenstein J; Wullich B; Rübe C
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1112-9. PubMed ID: 16979844
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
    Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preventing radiation retinopathy with hyperfractionation.
    Monroe AT; Bhandare N; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):856-64. PubMed ID: 15708266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
    Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.
    Koom WS; Chung EJ; Yang WI; Shim SJ; Suh CO; Roh JK; Yoon JH; Kim GE
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1127-37. PubMed ID: 15234048
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients.
    Ortholan C; Hannoun-Lévi JM; Ferrero JM; Largillier R; Courdi A
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):154-62. PubMed ID: 15629606
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy.
    Cho EI; Sasaki CT; Haffty BG
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1135-40. PubMed ID: 15001255
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma.
    Zhao KL; Shi XH; Jiang GL; Wang Y
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):123-9. PubMed ID: 15337547
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer.
    Rades D; Setter C; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1134-42. PubMed ID: 18258387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Movsas B; Diratzouian H; Hanlon A; Cooper H; Freedman G; Konski A; Sigurdson E; Hoffman J; Meropol NJ; Weiner LM; Coia L; Lanciano R; Stein J; Kister D; Eisenberg B
    Am J Clin Oncol; 2006 Oct; 29(5):435-41. PubMed ID: 17023775
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions.
    Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):549-62. PubMed ID: 7558943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
    Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 77. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
    Jeremić B; Milicić B
    Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
    J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.